Original document(9 pages)  中文版
    The invention relates to novel formula of heterochrome ketone-4 derivatives, and its pharmaceutical acceptable salt. In which R1 said hydrogen or C1 to C8 of linear or branched alkyl chain, R2, R3 same or different, said hydrogen or C1 to C8 straight or branched chain alkyl or C1 to C8 acyl. The invention also involved in the preparation of compounds, the drug combinations with active ingredient of this compounds, as well as the application of this compounds and medicinal combinations in the treatment of hypertension.
Application Number
申请号		 200710019203 Application Date
申请日		 2007.01.04
Title 名称 Isochromanone 4 derivate, its preparation process and therapeutic use
Publication Number
公开号		 100999512 Publication Date
公开日		 2007.07.18
Approval Pub. Date Granted Pub. Date
International Classification 分类号 C07D311/76;A61K31/352;A61P9/12
Applicant(s) Name
申请人		 China Medical Univ.
Address 地址
Inventor(s) Name 发明人 Wu Xiaoming;Huang Wenlong;Qian Hai;Liu Jie;Fu Jihua;Rao Guangling
Attorney & Agent 代理人

  
Polyglutaminic acid or sodium polyglutamate taxinine A ester compound and use thereof
Water soluble cephalotaxin phosphorus poly aminoacid ester or its salt, pharmaceutical compositions contg. same, and pharmaceutical use thereof
Water-soluble powder injection of ormosin VI and its preparing process and application
Polygonum tataricum tea and producing method
N-aryl substituted-1H-pyrrole derivative possessing cardiovascular activity
Network security controller of computer
Method for preparing cooked nourished wheat and rice
Use of isochromanone 4 derivative
Construction and method for ecologically eradicating Oncomelania hupensis Gredler with high glucosindate rape
Method of synthesizing 3-methyl-7-,8-dihydroxyisochromanone-4
Note:All patent data come from State Intellectual Property Office of the People's Republic of China. If there were discrepancies between here and the State Intellectual Property office, the later is more accurate. The patent data is only for public exchange and learning purposes. We are not responsible for the adverse consequences with unverified use of the data.